Affix Impex

Tavin EM Tablet is a combination of two anti-HIV medicines: Emtricitabine and Tenofovir disoproxil fumarate. They prevent HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood.

Trustiva Tablet 30's belongs to the group of medicines called antiretroviral therapy. Trustiva Tablet 30's contains Emtricitabine, Tenofovir Disoproxil Fumarate and Efavirenz. Trustiva Tablet 30's works by inhibiting the reverse transcriptase enzyme production, which is necessary to multiply the viruses. This effect helps to inhibit viral replication and treats HIV infection.

Directions for UseTrustiva Tablet 30's should be swallowed as a whole with a glass of water. Do not crush, chew, or break it. It should be taken on an empty stomach 1 hour before or 2 hours after a meal, preferably at bedtime. Your doctor will prescribe the dose and duration based on your health condition.

Zyzolide 600mg Tablet is an antibiotic medicine used in the treatment of severe bacterial infections. It is used to treat infections of the lungs (pneumonia), skin, and soft tissues.

Zyzolide 600mg Tablet may be taken with or without food, preferably at a fixed time. You should take it regularly as per the schedule prescribed by your doctor. Taking it at the same time every day will help you to remember to take it. Do not stop taking it until you have finished the complete course, even when you feel better. If you stop taking this medicine too early then infection may return or worsen.

The most common side effects of Zyzolide 600mg Tablet include vomiting, headache, nausea, decreased blood cell counts, and diarrhea. These are usually mild but let your doctor know if they bother you or last more than a few days.

Before using it, you should tell your doctor if you are allergic to any antibiotics or have any kidney or liver problems. You should also let your doctor know all other medicines you are taking as they may affect, or be affected by this medicine. Pregnant and breastfeeding mothers should consult their doctor before using it.

BENEFITS OF PROLAVIR LR TABLETIn HIV infectionProlavir LR Tablet prevents the HIV virus from multiplying in your body. It helps control the infection and makes your immune system work better. This lowers your chances of getting complications such as new infections and improves your quality of life.
It is not a cure of HIV or AIDS and should not be used to prevent HIV after accidental exposure to a risk. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor. Taking all doses in the right amount at the right times greatly increases the effectiveness of your combination of medicines and reduces the chances of your HIV infection becoming resistant to antiretroviral medicines. However, taking this medicine will not prevent you from passing HIV to other people.

Raltegravir 400mg Tablets (Zepdon and Isentress Generic) is an antiretrovirals. It is used to treat HIV (human immunodeficiency virus), the virus that can cause AIDS (acquired immunodeficiency syndrome). It prevents the multiplication of viruses in human cells and clears up your infection.

The combination of lopinavir and ritonavir is used with other medications to treat human immunodeficiency virus (HIV) infection. Lopinavir and ritonavir are in a class of medications called protease inhibitors. They work by decreasing the amount of HIV in the blood

Sofokast plus tablets, which contain 400 mg Sofosbuvir is a nucleotide polymerase inhibitor, and includes antiviral drugs direct action. sofosbuvir is exposed to have a high barrier to growth resistance and inhibits the Cb NS5B Hep protein. Thus, Sofosbuvir interferes with the enzyme RNA polymerase by a cell worker who can perform the reproduction process. Consequently, Sofosbuvir stops hepatitis C virus replication and reduces the amount of Hep C virus in the liver. Sofosbuvir also acts to reduce liver damage and improve liver function.

Sofokast plus tablets also contains daclatasvir, a direct-acting antiviral drug that is indicated for a patient affected by hepatitis C virus infection. It will target the Hep C virus and stops numerous steps in the HCV reproduction process by preventing viral particles from making copies themselves, and helps the body remove the virus from the blood.

Absorption: –

Peak plasma concentration is 0. 5-2 h after dose for 40% Sofosbuvir and in metabolite GS-331007 peak plasma concentration obtained 2-4 hours after administration where, as in Daclatasvir, peak plasma plasma concentration is within 2 hours after dose administration and bioavailability is 67%

Food effect:

Sofosbuvir 400 mg and metabolite do not affect fatty flour. Hence, Sofosbuvir is managed without food. In Daclatasvir, 60 mg of the drug was not taken with or without food.

Distribution:

Sofosbuvir 400 mg is about 51-65% bound to human plasma proteins, and the metabolite GS-331007 has minimal binding to human plasma proteins. And in Daclatasvir 60 mg protein binding protein is 99%

Metabolism:

In the liver, Sofosbuvir 400 mg is extensively metabolized (4% and> 90%) to be converted into the pharmacologically active nucleoside analog of GS – 461203 triphosphate. Daclatasvir 60 mg metabolism based on CYP3A substrate with initial CYP isoform.

Elimination:

The average total recovery dose of 400 mg Sofosbuvir was> 92% and included removal of 80%, 14% and 2, 5% in urine, feces, exhaled air. After a single dose Daclatasvir 60 mg radioactivity recovered to 88% via the faeces and 6, 6% through urine
Half the life of Sofosbuvir 400 mg and GS-331007 was 0, 4 and 27 hours, and Daclatasvir 60 mg had a half-life of 12 to 15 hours

Sofokast plus tablets also contains daclatasvir, a direct-acting antiviral drug that is indicated for a patient affected by hepatitis C virus infection. It will target the Hep C virus and stops numerous steps in the HCV reproduction process by preventing viral particles from making copies themselves, and helps the body remove the virus from the blood.

Absorption: –

Peak plasma concentration is 0. 5-2 h after dose for 40% Sofosbuvir and in metabolite GS-331007 peak plasma concentration obtained 2-4 hours after administration where, as in Daclatasvir, peak plasma plasma concentration is within 2 hours after dose administration and bioavailability is 67%

Food effect:

Sofosbuvir 400 mg and metabolite do not affect fatty flour. Hence, Sofosbuvir is managed without food. In Daclatasvir, 60 mg of the drug was not taken with or without food.

Distribution:

Sofosbuvir 400 mg is about 51-65% bound to human plasma proteins, and the metabolite GS-331007 has minimal binding to human plasma proteins. And in Daclatasvir 60 mg protein binding protein is 99%